Safety and efficacy at 240 weeks of different raltegravir formulations in children with HIV-1: a phase 1/2 open label, non-randomised, multicentre trial.

Journal: The lancet. HIV

Publication Year: 2019

Authors & Co-authors:  Nachman Alvero Teppler Homony Rodgers Graham Fenton Frenkel Browning Hazra